يعرض 1 - 10 نتائج من 139 نتيجة بحث عن '"monocyte chemotactic protein 1/ec [Endogenous Compound]"', وقت الاستعلام: 1.23s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: kidney function, kidney tubule cell, kidney tubule necrosis, macrophage migration, male, mouse, mRNA expression level, myofibroblast, neutrophil chemotaxis, nonhuman, primary culture, renal ischemia reperfusion injury, renal protection, alpha smooth muscle actin/ec [Endogenous Compound], buprenorphine/sc [Subcutaneous Drug Administration], carprofen/sc [Subcutaneous Drug Administration], CD68 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cyclophilin/ec [Endogenous Compound], cyclophilin A/ec [Endogenous Compound], cyclophilin D/ec [Endogenous Compound], cyclophilin inhibitor/cr [Drug Concentration], cyclophilin inhibitor/do [Drug Dose], cyclophilin inhibitor/dt [Drug Therapy], cyclophilin inhibitor/po [Oral Drug Administration], cyclophilin inhibitor/pd [Pharmacology], interleukin 2/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], oxygen radical, platelet derived growth factor B/ec [Endogenous Compound], stress activated protein kinase/ec [Endogenous Compound], transforming growth factor beta1/ec [Endogenous Compound], tubulin, tumor necrosis factor/ec [Endogenous Compound], unclassified drug, gs 642362/cr [Drug Concentration], gs 642362/do [Drug Dose], gs 642362/dt [Drug Therapy], gs 642362/po [Oral Drug Administration], gs 642362/pd [Pharmacology], ureter obstruction, acute kidney failure/dt [Drug Therapy], animal cell, animal experiment, animal model, animal tissue, article, cell death, controlled study, dose response, drug blood level, drug dose comparison, drug efficacy, EC90, enzyme inhibition, experimental renal failure, glomerulus capillary, immunohistochemistry, in vivo study, kidney fibrosis/dt [Drug Therapy], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28557Test
    International Journal of Molecular Sciences
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422Test
    Trends in Pharmacological Sciences
    Click here for full text options
    LibKey Link

  3. 3
    مورد إلكتروني

    مصطلحات الفهرس: kidney function, kidney tubule cell, kidney tubule necrosis, macrophage migration, male, mouse, mRNA expression level, myofibroblast, neutrophil chemotaxis, nonhuman, primary culture, renal ischemia reperfusion injury, renal protection, alpha smooth muscle actin/ec [Endogenous Compound], buprenorphine/sc [Subcutaneous Drug Administration], carprofen/sc [Subcutaneous Drug Administration], CD68 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cyclophilin/ec [Endogenous Compound], cyclophilin A/ec [Endogenous Compound], cyclophilin D/ec [Endogenous Compound], cyclophilin inhibitor/cr [Drug Concentration], cyclophilin inhibitor/do [Drug Dose], cyclophilin inhibitor/dt [Drug Therapy], cyclophilin inhibitor/po [Oral Drug Administration], cyclophilin inhibitor/pd [Pharmacology], interleukin 2/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], oxygen radical, platelet derived growth factor B/ec [Endogenous Compound], stress activated protein kinase/ec [Endogenous Compound], transforming growth factor beta1/ec [Endogenous Compound], tubulin, tumor necrosis factor/ec [Endogenous Compound], unclassified drug, gs 642362/cr [Drug Concentration], gs 642362/do [Drug Dose], gs 642362/dt [Drug Therapy], gs 642362/po [Oral Drug Administration], gs 642362/pd [Pharmacology], ureter obstruction, acute kidney failure/dt [Drug Therapy], animal cell, animal experiment, animal model, animal tissue, article, cell death, controlled study, dose response, drug blood level, drug dose comparison, drug efficacy, EC90, enzyme inhibition, experimental renal failure, glomerulus capillary, immunohistochemistry, in vivo study, kidney fibrosis/dt [Drug Therapy], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28557Test
    International Journal of Molecular Sciences
    LibKey Link

  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422Test
    Trends in Pharmacological Sciences
    LibKey Link

  5. 5
    مورد إلكتروني
  6. 6
  7. 7
    مورد إلكتروني
  8. 8
  9. 9
  10. 10
    مورد إلكتروني

    مصطلحات الفهرس: developmental disorder, BOLD signal, brain blood flow, brain calcification, brain histology, brain injury, cardiovascular risk, clinical trial (topic), conservative treatment, diffusion weighted imaging, disease association, disorders of higher cerebral function, electroencephalography monitoring, fetus outcome, functional near-infrared spectroscopy, functional neuroimaging, genome analysis, hemodynamic parameters, human, hypoxia, immunomodulation, immunopathology, inflammation, intrauterine growth retardation, low birth weight, malnutrition, metabolic disorder, nanomedicine, nervous system inflammation, neuromonitoring, neuropathology, nonhuman, outcome assessment, overnutrition, perinatal asphyxia, placenta disorder, placenta insufficiency, postnatal care, pregnancy complication, pregnancy diabetes mellitus, prenatal care, review, single nucleotide polymorphism, small for date infant, stillbirth, alpha fetoprotein/ec [Endogenous Compound], chorionic gonadotropin/ec [Endogenous Compound], creatine/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], indoleamine 2,3 dioxygenase/ec [Endogenous Compound], inhibin A/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], leptin/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], nanoparticle, placental growth factor/ec [Endogenous Compound], pregnancy associated plasma protein A/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], electroencephalograph, nuclear magnetic resonance scanner, brain sparing, autoregulation, biochemical analysis, blood oxygenation, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36128Test
    Frontiers in Endocrinology
    Click here for full text options
    LibKey Link